Oral Fluid Testing for Drugs of Abuse: Positive Prevalence Rates by Intercept Immunoassay Screening and GC-MS-MS Confirmation and Suggested Cutoff Concentrations
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Draft guidelines for the use of oral fluid for workplace drug testing are under development by the Substance Abuse and Mental Health Services Administration (SAMHSA) in cooperation with industry and researchers. Comparison studies of the effectiveness of oral fluid testing versus urine testing are needed to establish scientifically reliable cutoff concentrations for oral fluid testing. We present the results of the first large scale database on oral fluid testing in private industry. A total of 77,218 oral fluid specimens were tested over the period of January through October 2001 at LabOne. Specimens were screened by Intercept immunoassay at manufacturer's recommended cutoff concentrations for the five SAMHSA drug categories (marijuana, cocaine, opiates, phencyclidine, and amphetamines). Presumptive positive specimens were confirmed by gas chromatography-tandem mass spectrometry. A total of 3908 positive tests were reported over the 10-month period, representing a positive rate of 5.06%. Of the five drug categories, marijuana and cocaine accounted for 85.75% of the positives. The pattern and frequency of drug positives showed remarkable similarity to urine drug prevalence rates reported for the general workforce according to the Quest Diagnostics' Drug Testing Index over the same general period, suggesting that oral fluid testing produces equivalent results to urine testing. The data on oral fluid testing also revealed a surprisingly high 66.7% prevalence of 6-acetylmorphine confirmations for morphine positives suggesting that oral fluid testing may be superior in some cases to urine testing. Comparison of oral fluid drug concentrations to SAMHSA-recommended cutoff concentrations in Draft Guidelines indicated that adoption of the screening and confirmation cutoff concentrations of Draft Guidelines #3 would produce the most consistent reporting results for all drug classes except amphetamines. Consequently, it is suggested that the final Guidelines adopt the screening and cutoff concentrations listed in Draft Guidelines #3 with the exception of lowering the amphetamines cutoff concentrations (screening/confirmation) to 50/50 ng/mL for amphetamine and methamphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma
Jenkins, A. J., Oyler, J. M., & Cone, E. J. (1995) · Journal of Analytical Toxicology · doi:10.1093/jat/19.6.359 · Cited by 181
Self-citation
Cited by
A Single-Question Screening Test for Drug Use in Primary Care
Smith, P. C., Schmidt, S. M., Allensworth-Davies, D., & Saitz, R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.140 · Cited by 484
McNeely, J., Wu, L.-T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0317 · Cited by 320
(2006) · PubMed Central · Cited by 241
Development of the treatment outcomes profile
Marsden, J., Farrell, M., Bradbury, C., Dale‐Perera, A., Eastwood, B., Roxburgh, M., & Taylor, S. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02284.x · Cited by 194
Oral fluid drug testing: analytical approaches, issues and interpretation of results
Desrosiers, N. A., & Huestis, M. A. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz048 · Cited by 123
Metadata
- Authors
- Cone, E. J., Presley, L., Lehrer, M., Seiter, W., Smith, M., Kardos, K. W., Fritch, D., Salamone, S., & Niedbala, R. S.
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-01
- Volume
- 26
- Issue
- 8
- Pages
- 541-546
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2130480806
- Cited by
- 112
- References
- 1
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.